ES2081810T3 - Derivados de 4-fenil-4-(n-(2-fluorofenil)amido)-piperidina. - Google Patents

Derivados de 4-fenil-4-(n-(2-fluorofenil)amido)-piperidina.

Info

Publication number
ES2081810T3
ES2081810T3 ES88310259T ES88310259T ES2081810T3 ES 2081810 T3 ES2081810 T3 ES 2081810T3 ES 88310259 T ES88310259 T ES 88310259T ES 88310259 T ES88310259 T ES 88310259T ES 2081810 T3 ES2081810 T3 ES 2081810T3
Authority
ES
Spain
Prior art keywords
rent
phenyl
lower alkyl
dihydro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88310259T
Other languages
English (en)
Inventor
Linas V Kudzma
H Kenneth Spencer
Sherry A Severnak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OHMEDA PHARMA PROD
Datex Ohmeda Inc
Original Assignee
OHMEDA PHARMA PROD
Ohmeda Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OHMEDA PHARMA PROD, Ohmeda Inc filed Critical OHMEDA PHARMA PROD
Application granted granted Critical
Publication of ES2081810T3 publication Critical patent/ES2081810T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

COMPUESTOS DE LA FORMULA(I), Y/O SALES DE ADICION ACIDAS ACEPTABLES FARMACEUTICAMENTE DE ESTOS, EN DONDE R1 ES FENILO; R2 ES FENILO NO SUSTITUIDO O SUSTITUIDO CON UNO O MAS HALOGENOS; R3 ES UN ALQUILO INFERIOR, UN CICLOALQUILO INFERIOR O UN ALCOXI INFERIOR, GRUPO ALQUILO INFERIOR; Y L ES UN GRUPO ALQUENILO INFERIOR O UN GRUPO ALQUILO INFERIOR SUSTITUIDO QUE ES TIENIL ALQUILO INFERIOR, TIAZOLIL ALQUILO INFERIOR; [4 - (ALQUILO INFERIOR)TIAZOIL]ALQUILO INFERIOR; [4,5 - DIHIDRO - 5 - OXO - 1H - TETRAZOL - Y - 1 - YL)ALQUILO INFERIOR; [4 - (ALQUILO INFERIOR) - 4,5 - DIHIDRO - 5 - OXO - 1H - TETRAZOL - 1 - IL93ALQUILO INFERIOR; 1H - PIRAZOLIL ALQUILO INFERIOR , 2 - (2 - DIHIDRO - 2 - OXO - 3H - BENZOXAZOL - 3 - IL)ALQUILO INFERIOR) - 5 - NITRO 1H - IMIDAZOL - 1 - IL93ALQUILO INFERIOR; 914 - (HALO) - 1H PIRAZOLIL93ALQUILO INFERIOR SUSTITUIDO EN POSCION 4 POR UN HALOGENO, CICLOALQUILO INFERIOR, ALQUILO INFERIOR O FENILO ALQUILO INFERIOR TIENEN PROPIEDADES ANALGESICAS.
ES88310259T 1987-11-02 1988-11-01 Derivados de 4-fenil-4-(n-(2-fluorofenil)amido)-piperidina. Expired - Lifetime ES2081810T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/115,284 US4791121A (en) 1987-11-02 1987-11-02 4-phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds

Publications (1)

Publication Number Publication Date
ES2081810T3 true ES2081810T3 (es) 1996-03-16

Family

ID=22360366

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88310259T Expired - Lifetime ES2081810T3 (es) 1987-11-02 1988-11-01 Derivados de 4-fenil-4-(n-(2-fluorofenil)amido)-piperidina.

Country Status (16)

Country Link
US (1) US4791121A (es)
EP (1) EP0315405B1 (es)
JP (2) JPH02152963A (es)
KR (1) KR970008313B1 (es)
CN (1) CN1020723C (es)
AU (1) AU611728B2 (es)
CA (1) CA1334416C (es)
DE (1) DE3854938T2 (es)
DK (1) DK172787B1 (es)
ES (1) ES2081810T3 (es)
FI (1) FI885035A (es)
GR (1) GR3019342T3 (es)
IL (1) IL88140A0 (es)
MX (1) MX9203140A (es)
NO (1) NO172691C (es)
NZ (1) NZ226634A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871749A (en) * 1987-12-31 1989-10-03 Boc, Inc. 4-heteropentacyclic-4-(N-(phenyl)amido) piperidine derivatives and pharamaceutical compositions and method employing such compounds
US4868194A (en) * 1988-09-23 1989-09-19 Merrell Dow Pharmaceuticals Inc. Imidazole antiarrhythmics
KR900016129A (ko) * 1989-04-20 1990-11-12 테리 아아르 커세트 4-알콕시알킬-4-아미노페닐피페리딘 및 그들의 유도체의 제조 방법
US4939161A (en) * 1989-05-12 1990-07-03 Boc, Inc. Analgesic N-aryl-N-[1-substituted-3,5-dimethyl-4-piperidinyl]amides
FR2678267B1 (fr) * 1991-06-25 1994-02-04 Elf Sanofi Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2725986B1 (fr) * 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
WO2007061555A1 (en) * 2005-11-17 2007-05-31 Mallinckrodt Inc. Process for synthesizing remifentanil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3161637A (en) * 1961-10-10 1964-12-15 Res Lab Dr C Janssen N V 1-(gamma-aroyl-propyl)-4-(nu-arylcarbonyl amino) piperidines and related compounds
NL284196A (es) * 1961-10-10
US3998834A (en) * 1975-03-14 1976-12-21 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-n-phenylamides and -carbamates
US4196210A (en) * 1975-09-23 1980-04-01 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne

Also Published As

Publication number Publication date
IL88140A0 (en) 1989-06-30
CN1041585A (zh) 1990-04-25
NZ226634A (en) 1990-07-26
CN1020723C (zh) 1993-05-19
NO172691B (no) 1993-05-18
KR890008094A (ko) 1989-07-08
FI885035A0 (fi) 1988-11-01
EP0315405A1 (en) 1989-05-10
DK607988A (da) 1989-05-03
DE3854938D1 (de) 1996-03-07
NO172691C (no) 1993-08-25
JPH0552834B2 (es) 1993-08-06
DK607988D0 (da) 1988-11-01
US4791121A (en) 1988-12-13
GR3019342T3 (en) 1996-06-30
AU611728B2 (en) 1991-06-20
JPH02152963A (ja) 1990-06-12
MX9203140A (es) 1992-07-01
JPH0215061A (ja) 1990-01-18
CA1334416C (en) 1995-02-14
EP0315405B1 (en) 1996-01-24
KR970008313B1 (ko) 1997-05-23
DE3854938T2 (de) 1996-05-30
NO884842D0 (no) 1988-10-31
DK172787B1 (da) 1999-07-19
NO884842L (no) 1989-05-03
AU2455888A (en) 1989-05-04
FI885035A (fi) 1989-05-03

Similar Documents

Publication Publication Date Title
DK0574313T3 (da) 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme
DE69327541T2 (de) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
NO934502D0 (no) Nye sulfonamider
CL2003002756A1 (es) Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia.
DE69232568T2 (de) Cyclische Harnstoffe und Analoga verwendbar als retrovirale Proteasehemmer
DK0646115T3 (da) Heterocykliske/cykliske aminderivater
MX9304215A (es) Nuevos derivados piperidinicos del bencimidazol.
ES2149869T3 (es) Derivados de indol sustituidos por formil o ciano con actividad dopominergica.
DE69414398D1 (de) Heterocyclische neurokinin-antagonisten
NO873568L (no) Alfa-alkyl-4-amino-kinolinmetanoler og 1-(4-aralkylamino-3-kinolinyl)alkanoler, samt fremgangsmaate for fremstilling derav.
ES2081810T3 (es) Derivados de 4-fenil-4-(n-(2-fluorofenil)amido)-piperidina.
NO180632C (no) 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler
DK0637586T3 (da) 2-(Piperidin-4-yl, pyridin-4-yl og tetrahydropyridin-4-yl)-benzofuran-7-carbamatderivater, deres fremstilling og anvendelse
NZ333513A (en) 1,4-di-substituted piperidines and medicaments useful as muscarinic antagonists
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
FI925801A0 (fi) Piperidyl-substituerade indoler
ATE295183T1 (de) Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
NO922380L (no) Substituerte 4-fenyl-4-piperidinkarboksamider med baade lokal anestetisk og analgetisk effekt samt fremgangsmaater for deres fremstilling
ATE139441T1 (de) Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe
DE69214586T2 (de) Methanoanthracene als Dopaminantagonisten
EA199900667A1 (ru) Замещенный 4-(6-фтор-(1h)-индол-3-ил)-1,2,3,6-тетрагидропиридин для лечения нарушений цнс
DK599486A (da) 1,4-dihydropyridiner, deres fremstilling af anvendelse som laegemidler
ES2074472T3 (es) Procedimiento de preparacion de un derivado de la 1,4-dihidro-piridina, la (-)-2-((2-(2-amino-etoxi)-etoxi)-metil)-4-(2,3-dicloro-fenil)-3-etoxi-carbonil-5-metoxi-carbonil-6-metil-1,4-dihidro-piridina y de sus sales.
IE41708L (en) 2,6-dioxo-tetra- and -hexa-hydropyridine derivatives
SG47556A1 (en) N-[3-[2-(1H-imidazol-1-yl) ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 315405

Country of ref document: ES